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Background: In the past decade, there have been many enhancements in cardiac pac- 
ing leads (PL), steroid-elusion (SE) beinq the most sianificant. 
815-1 Prenatally Diagnosed Complete Atrioventricular Block Objective: We assessed: 1) if SE PL &ult in lower chronic pacing (P) or sensing (S) 
With and Without Structural Heart Disease in the 1990s: 
thresholds (TH) compared with newer non-SE leads, and 2) if the P or S TH response to 
Management and Impact on Outcome 
PL implantation was dependent on the chamber of application, whether deployed on the 
epi- or endocardium, patient gender or presence of heart disease. 
Edaar T. Java@, Jean-Claude Fouron, Jeffrey Smallhom, Franc~ne Proulx, Lisa K. 
Homberger. The Hospital for Sick Children, Toronto, ON, Canada, Saints-Justine 
Hospital, Montreal, PQ, Canada 
Methods: Between 7195 and 6100, 74 patients ranging in age from 1 day to 39 years 
undewent implantation of 126 PL, 61 were SE, and 67 were non-SE PL. Forty-eight 
patients had heatt disease. 
Background: Complete AV block (CAVE) is associated with a significant fetal and neo- 
natal morbidity and mortality. The emergence of transplacental treatment modalities (ste- 
roids: @.ympathomimetics for ventricular rates ( 55 beatslminute) and progress in 
neonatal cars may have improved the prognosis of affected fetuses in recent years. 
We sought to study the clinical course. prenatal management and outcome of fetuses 
with a diagnosis of CAVB at 2 tertiary care centers between 1990 and 2000. 
Methods and results: Fifty fetuses were detected at 24 _+ 5 weeks gestation. In 22 
cases CAVB was associated with structural heart disease, mainly left atrial ~somar~sm 
&AI: n=l5) and congenitally corrected transposition (I-TGA; n=3). At the Initial presenta- 
tion 10122 had ventricular rates of -< 55 beats/minute, 5 (23%) of whom were hydropic. 
Only 2 fetuses with LAI received treatment with @ympathomimetics and both died as 
neonates. Overall, 19122 (66%) with structural heart disease died in utero (LAI: 1 l/i 5) or 
as neonates (LAI: 314; I-TGA: l/3). The remaining 28 fetuses had normal cardiac anat- 
omy. most of which (92%) were associated with maternal anti-%/anti-La autoantibodies. 
Thirteen of the 28 had ventricular rates 5 55 beats par minute, but only 1 was hydropic at 
presentation. In cases with isolated CAVB. fetal and neonatal survival was signifipntly 
better with maternal sympathomimetic treatment when compared to untreated cases (6/7 
versus l/6; P < 0.05). Seventeen of 24 pregnancies with autoimmune antibodies were 
treated with maternal dexamethasone and only 3 (16%) did not suwive the neonatal 
period, while 4 of 7 cases (44%) without steroid therapy died (P < 0.02). 
Conclusions: Complete AV block associated with structural heart disease contwes to 
be associated with poor fetal and perinatal outcome. Transpfacental anti-inflammatory 
therapy with steroids, combined with &sympathomimetics at fetal heart rates ( 55 beats 
per minute appears to improve the outcome of fetuses with CAVB and structurally normal 
hearts. 
11:15a.m. 
015-2 Implantable Cardioverter Defibrillators in Children and 
Adolescents: A Reassessment of Indications 
Robert H. Pass, Leonardo Liberman, Henry M. Spotnitz, John J. Lambem. Aflan J. 
Hordof, NY Presbyterian Hospital - Children’s Hospital of NY Columbia University, NY, 
NY 
Background: Although established criteria exist for ICD implantation in children and ado- 
lescents, questions remain as to the appropriateness of all indications. A review of all 
recent ICD implantations in children and adolescents in a single center over a nearly 5 yr 
period was undertaken with particular attention to indtcations and the relationship of 
these to delivety of appropriate device therapy or recording of life-threatening arrhyth- 
mias with aborted therapies in mid-term follow-up. 
Methods:From l/96 to 9/M, 24 patients < 21 yrs undenvent ICD implantation. Review of 
indications for implantation and mid-term follow-up usage of the device for the treatment 
or recording of ventricular arrhythmias was performed. 
Results: Median age at implantation was 13.9 yrs (mean 13.3; range 0.5-20.2). Indica- 
tions were hypertrophic cardiomyopathy (HCM) with syncope/abwted sudden death (6). 
dilated cardiomyopathy (DCM) with high grade VEA or history of aborted sudden death 
(6), structurally normal heart with syncope and positive EPS or aborted sudden death (5), 
long QT syndrome with torsades or family history of sudden death (LQTS; 4), and cate- 
chofaminergic VT (2). At a median follow-up of 17 months (mean 21; range l-46). 5124 
have received appropriate shocks from their device for a true ventricular arrhythmia. 316 
patients with HCM and 2/2 with catecholaminergic VT had appropriate device treatment 
of ventricular arrhythmias. There were no shocks or recorded arrhythmias in any patient 
with LOTS, DCM or a structurally normal heart with history of aborted sudden death or 
positive EPS. All DCM patients were treated with maximal anticongestive regwnens. All 
LQTS and HCM patients and l/2 catecholaminergic VT pattents were treated with beta 
blockers. 
Conclusions: Patients wth HCM and syncope as well as those with catecholaminergic 
VT may be the two pediatric groups with the most clear indication for ICD implantation. At 
mid-term follow-up the specific indications for ICI% in children and adolescents with 
DCM with syncope or high grade ectopy, structurally normal hearts and aborted sudden 
death or syncope with positive EPS, and LQTS are still not well established. 
Results: 1) SE and non-SE PL had similar acute P and S TH. 2) P TH increases at 1 
month was significantly less in the SE group. 3) At 24 months, SE PL had a lower P TH, 
the effect of which was independent of dexamethasone. 4) No change in the atrlal or van- 
trkxlar S TH was observed from the time of implantation to 24 months. 5) Multiple linear 
regression analysis Identified heart disease and patient gender as independent factors 
significantly affecting P and S TH changes. 6) No significant differences in P or S TH 
were evident between epicardial and endocardial PL. 
Implant 1 Month 24 Months P-Value 
O-l mo, O-24 mo 
Atrium Pacing TH- SE 0.64kO.33 0.63r0.35 0.91*0.39 ‘,NS 
(Vat 0.5 msec) 
Non- SE 0.76 * 0.43 1.61 ztO.77 1.4 * 0.44 *, NS 
P-Value SE vs. Non-SE NS I * 
Ventricular Pacing TH- SE 0.64 f 0.28 0.69 2 0.26 1.06 * 0.43 *, NS 
(Vat 0.5 msec) 
Non-SE 0.66 kO.38 1.62 il.22 1.6 * 0.92 *, NS 
P-Value SE vs. Non-SE NS I f 
Atrial Sensing TH- SE 
(rw 
Non-SE 
P-Value SE vs. Non-SE 
Ventricular Sensing TH 
@V) 
Non- SE 
P-Value SE vs. Non-SE 
3.4 * 1.1 3.2 * 1.2 3.2-1.2 NS, NS 
3.3* 1.1 3.1 * 1.1 3.2+1.0 NS, NS 
NS NS NS 
9.2 * 2.2 9.5 * 2.6 9.1 * 2.6 NS, NS 
6.5 t 2.3 8.4 * 3.5 8.4 * 2.9 NS. NS 
NS NS NS 
* = p< 0.05, Mean f SD 
Conclusions: SE PL have a small effect in decreasing chronic atrial and ventricular P 
TH, independent of whether the L was implanted on the epicardium or endocardium. This 
effect was the result of blunting the early P TH rise noted after lead implantation. SE PL 
had no effect on atrial or ventricular S TH. 
11:4.5 a.m. 
815-4 Acute Hemodynamic Improvement With Multisite 
Pacing Following Surgery for Congenital Heart Disease 
Frank J. Zimmerman, Joanne P. Starr, Peter Koenig, Patricia Smith, Emile A. Bacha, 
University of Chicago, Chicago, IL 
Cardiac dysfunction in the immediate post-operative period following congenital heart 
disease (CHD) surgery is a major cause of morbidity. Cardiac resynchronization through 
multisite pacing has been shown to improve cardiac index (Cl) in pts with heart fallwe 
and interventricular conduction delay (IVCD). 
Obiective: The aim of this studv was to assess the acute hemodvnamic effects of multi- 
site ventncular pacing in pts following surgery for congenital heart disease. 
Methods: The acute hemodvnamic studv was conducted in 30 ots with IVCD (ages 1 
week to 17 years) following surgery for CHD (post-op day O-6). Epicardial pacing leads 
were placed during surgely on the RV free wall and RV outflow tract or oppwte free 
wall. Blood pressure (BP), systemic and mixed venous oxygen saturations, ECG’s and 
echocardiograms were obtained in the baseline state and after 20 minutes of multisite 
ventricular pacing. 
Reaufts: The pts were grouped by anatomic diagnosis as follows: group I= single ventri- 
cle (II= 14), group P=ventricular surgery (tetralogy of Faflot, VSD) (n=ll), group 3=other 
(n=5). QRS duration was prolonged for age in all pts (RBBB in 9. IVCD in 17, LBBB in 4). 
Multisite ventricular pacing resulted in a significant decrease in the QRS duration in all 
pts (106 vs 60 msec. 23% chanae. D ~0.005). Svstofic BP imoroved in all ots with pacing 
i69.6 vs 98.4 mmHg. 9.7% change; p<O.OO$ df improved with pacing in’ 19/21 pts with 
no chaws ln 2 ots (3.5 vs 4.0 Uminlm2. 15% chaws. 0<0.00011. In 2 ots. multisite pac- 
ing ins&ted in the OR facilitated weaning from cardiopulmonary bypass (CPB). 
Echocardiograms were performed in 10 pts. MV inflow pattern was not significantly differ- 
ent with pacing. The degree of increase in Cl did not correlate with cross clamp time, 
